India to resume vaccine exports to poor countries in Covax programme
Reuters reported that India, the world’s biggest vaccine manufacturer, will resume exports of Covid-19 vaccines from the next quarter, prioritising the global vaccine sharing platform, Covax, and neighbouring countries. Indian companies have set up the capacity to produce nearly 3 -bn vaccine doses a year. The country had donated or sold 66-m doses to nearly 100 countries before the exports were halted. India wants to vaccinate all its 944-m adults by December and has so far given at least one dose to 64% of them and two doses to 22%.